# Indoco Remedies Ltd (INDOCO)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹199.08
Day Change: -2.55%
52W High: ₹348.1
52W Low: ₹190
Market Cap: ₹2,074 Cr

## Valuation
P/E: 0
P/B: 1.82
EPS: ₹-12.17
Book Value: ₹111.55
Dividend Yield: 0.09%

## Returns
1Y Return: -19.71%

## Profitability
ROE: -10.12%
ROCE: -1.6%
Debt/Equity: 1.17
Revenue Growth: 21.9%
Profit Growth: 0%
EBITDA Margin: 7.68%
Operating Margin: 3.62%

## About
Indoco Remedies Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Indoco Remedies Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Demise
- Announcement: Announcement under Regulation 30 (LODR)-Press Release / Media Release
- BSE Filing: Announcement under Regulation 30 (LODR)-Demise

## Access
Current tier: anonymous
More history: Register free to see 12 more years.

## Data Freshness
Quote Updated: 2026-05-24T20:00:11.526Z
Price History Updated: 2026-05-18T22:58:56.375Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:56.375Z
Quant Updated: 2026-05-18T22:58:56.375Z
Sentiment Updated: 2026-05-18T22:58:56.375Z
Financials Status: current
Financials Updated: 2026-05-19T01:30:46.625Z
Financials Last Attempt: 2026-05-19T01:30:46.625Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹1641.29 Cr
Operating Profit: ₹-26.72 Cr (OPM -1.63%)
Net Profit: ₹-73.74 Cr
Tax: ₹3.58 Cr

## Annual P&L History
FY25: Rev ₹1641.29Cr | PAT ₹-73.74Cr | OPM -1.63%
FY24: Rev ₹1788.22Cr | PAT ₹98.46Cr | OPM 7.99%
FY23: Rev ₹1640.05Cr | PAT ₹142.25Cr | OPM 12.05%

## Balance Sheet (FY25)
Total Assets: ₹2429.91 Cr
Total Liabilities: ₹1411.54 Cr
Borrowings: ₹993.57 Cr
Cash: ₹12.1 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Suresh Govind Kare, Non-Executive Chairman & Whole time Director
- Sundeep Vasant Bambolkar, Joint MD & Executive Director
- Aditi Milind Panandikar, MD & Executive Director
- Pramod  Ghorpade, Chief Financial Officer
- Ramanathan N. Hariharan, Head of Legal, Company Secretary & Compliance Officer

---
Source: rupiya.io/stocks/indoco
Disclaimer: For research and education only. Not investment advice.